UK markets open in 1 hour 57 minutes

Unity Biotechnology, Inc. (0YC0.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.5350+0.0650 (+4.42%)
At close: 06:42PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.87
52-week change 3-8.43%
S&P500 52-week change 323.10%
52-week high 33.7880
52-week low 30.0000
50-day moving average 31.8256
200-day moving average 32.3144

Share statistics

Avg vol (3-month) 3551
Avg vol (10-day) 3618
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 814.51M
% held by insiders 11.25%
% held by institutions 128.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 320 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-25.30%
Return on equity (ttm)-94.36%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.28M
Net income avi to common (ttm)-39.86M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.2M
Total cash per share (mrq)2.57
Total debt (mrq)26.99M
Total debt/equity (mrq)95.04%
Current ratio (mrq)5.95
Book value per share (mrq)1.69

Cash flow statement

Operating cash flow (ttm)-37.09M
Levered free cash flow (ttm)-20.6M